COMMUNIQUÉS West-GlobeNewswire

Portola Pharmaceuticals Appoints Ernie Meyer as Executive Vice President and Chief Human Resources Officer
09/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc.® (Nasdaq:PTLA) today announced the appointment of Ernie Meyer as executive vice president and chief human resources officer, [...]
Krystal Biotech’s KB105 Granted Orphan Drug Designation by the FDA to Treat Patients With TGM-1 Deficient Autosomal Recessive Congenital Ichthyosis
09/08/2018
PITTSBURGH, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Krystal Biotech , Inc. (Nasdaq:KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases [...]
Cocrystal Pharma Reports 2018 Second Quarter Financial Results and Provides Corporate Update
09/08/2018
– First half of 2018 marked by management’s successful execution of corporate, clinical and regulatory strategies – – Topline results from Phase 2a study evaluating CC-31244 for ultra-short treatment of HCV expected in [...]
Precipio Appoints New Board Member to Replace Departing Director
09/08/2018
Kathy LaPorte brings 30-year track record of VC success financing and operating innovative biopharma, diagnostics and healthcare companies NEW HAVEN, Conn., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics [...]
Moleculin Seeks Approval from Polish Regulatory Agency for Skin Cancer Clinical Trial
09/08/2018
HOUSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
IMV Inc. Reaches Multiple Milestones in Advanced Ovarian Cancer Clinical Trial
09/08/2018
HALIFAX, Nova Scotia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Enrollment Completed for Phase 1b Cohorts First Dosing Occurred in Phase 2 Portion of the Program IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno- [...]
XOMA to Present at the 2018 Wedbush PacGrow Healthcare Conference and the 2018 Southern California Investor Conference
09/08/2018
EMERYVILLE, Calif., Aug. 09, 2018 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), a pioneer in the discovery, development and licensing of therapeutic antibodies, announced today its Chief Executive Officer, Jim [...]
Surgery Partners, Inc. Announces Second Quarter 2018 Results
09/08/2018
Strategic Initiatives Begin to Yield Near-Term Results, Position the Company for Significant Growth in 2019 and Beyond BRENTWOOD, Tenn., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery [...]
R1 RCM Reports Second Quarter 2018 Results
09/08/2018
CHICAGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management services to healthcare providers, today announced results for the three months ended [...]
Anavex Life Sciences Reports Fiscal Third Quarter 2018 Financial Results
09/08/2018
Conference Call and Webcast Today at 4:30 p.m. ET NEW YORK, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq:AVXL), a clinical-stage biopharmaceutical company developing [...]
Auxly Announces Receipt of Dealer’s Licence for Dosecann Facility
09/08/2018
VANCOUVER, British Columbia, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V:XLY) (" Auxly " or the " Company ") is pleased to announce that the Company’s wholly-owned subsidiary, Dosecann Inc. (“ [...]
ContraFect Announces Second Quarter 2018 Financial Results
09/08/2018
YONKERS, N.Y., Aug. 09, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Protalix BioTherapeutics Reports 2018 Second Quarter Results and Provides Corporate Update
09/08/2018
CARMIEL, Israel, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Protalix BioTherapeutics, Inc. (NYSE American:PLX, TASE:PLX), a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic [...]
Neuralstem Announces NSI-189 Granted Orphan Drug Designation from the U.S. FDA for the Treatment of Angelman Syndrome
09/08/2018
GERMANTOWN, Md., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell technology, today [...]
Idera Pharmaceuticals To Present at the 2018 Wedbush PacGrow Healthcare Conference
09/08/2018
EXTON, Pa., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ: IDRA), a pharmaceutical company focused on the development and commercialization of its proprietary immune modulator, tilsotolimod, for [...]
Pieris Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
09/08/2018
COMPANY TO HOST AN INVESTOR CONFERENCE CALL ON THURSDAY, AUGUST 9, 2018 AT 8:00 AM EDT BOSTON, Aug. 09, 2018 (GLOBE NEWSWIRE) -- Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS) , a clinical-stage biotechnology company [...]
Nabriva Therapeutics Reports Second Quarter 2018 Financial Results and Recent Corporate Highlights
09/08/2018
- Company preparing for potential commercialization of two first-in-class antibiotics, Lefamulin (IV and Oral) and CONTEPO (IV) in the United States in 2019 - - New Drug Application submissions expected in Q4 2018 - [...]
Ogilvy CommonHealth Worldwide continues growth with promotions and new hires
09/08/2018
PARSIPPANY, N.J., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Ogilvy CommonHealth Worldwide ( www.ogilvychww.com ), a WPP Health & Wellness company (NYSE: WPP) ( www.wpp.com ), announced five promotions and two new hires [...]
INSYS Therapeutics Appoints Elizabeth Bohlen to Board of Directors
09/08/2018
PHOENIX, Aug. 09, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced the [...]

Pages